RMTG expands Cellgenic commercial operations into Argentina
RMTG•Cellgenic expands in Argentina
Regenerative Medical Technology Group expanded Cellgenic’s Latin America operations by establishing a regulated commercial platform in Argentina.
Argentina is positioned as a South America hub for biologics distribution through licensed physicians, supported by compliance, training and technical resources.
Build-out and regional strategy
The build-out includes expanding the Argentina sales team, scaling distribution into neighboring markets, and growing physician education with ISSCA.
The move supports a broader strategy spanning physician education, biologics commercialization, lab capabilities and international distribution across more than 30 countries.
